Process View
Any process that modulates the frequency, rate or extent of calcium-mediated signaling, the process in which a cell uses calcium ions to convert an extracellular signal into a response.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of calcium mediated signaling"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
LCK | lymphocyte-specific protein tyrosine kinase | 0.999 | ||
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.920 | Mouse | |
LAT | linker for activation of T cells | 0.739 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.726 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.719 | ||
CD247 | CD247 molecule | 0.596 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.588 | ||
UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 0.510 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.385 | ||
CD3D | CD3d molecule, delta (CD3-TCR complex) | 0.271 | ||
PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.257 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.254 | ||
CD28 | CD28 molecule | 0.232 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.191 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.182 | Human | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.170 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.150 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.147 | Human | |
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.121 | ||
FYB | FYN binding protein | 0.118 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.114 | ||
PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.109 | ||
PLCG1 | phospholipase C, gamma 1 | 0.106 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.103 | Human | |
SYK | spleen tyrosine kinase | 0.101 | Mouse | |
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.100 | ||
ITK | IL2-inducible T-cell kinase | 0.095 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.090 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.088 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.085 | ||
TRPC4 | transient receptor potential cation channel, subfamily C, member 4 | 0.083 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.079 | Human | |
AXIN1 | axin 1 | 0.078 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.074 | ||
DSG2 | desmoglein 2 | 0.074 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.073 | ||
CD163 | CD163 molecule | 0.069 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.064 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.061 | ||
ITGB1BP3 | integrin beta 1 binding protein 3 | 0.060 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.058 | Human | |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.055 | Mouse | |
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.053 | ||
PLK3 | polo-like kinase 3 | 0.052 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.045 | ||
SLAMF8 | SLAM family member 8 | 0.044 | ||
IDE | insulin-degrading enzyme | 0.041 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.039 | ||
JUP | junction plakoglobin | 0.038 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.038 | ||
IL7R | interleukin 7 receptor | 0.037 | ||
CD2 | CD2 molecule | 0.035 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.034 | Human | |
CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.031 | ||
FHL1 | four and a half LIM domains 1 | 0.030 | ||
IL10 | interleukin 10 | 0.030 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.029 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.029 | ||
IL2RB | interleukin 2 receptor, beta | 0.029 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.029 | ||
IL1B | interleukin 1, beta | 0.029 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.028 | Human | |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.028 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.027 | ||
AQP9 | aquaporin 9 | 0.027 | ||
SH2D1A | SH2 domain containing 1A | 0.026 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.026 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.025 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.025 | ||
DSP | desmoplakin | 0.024 | ||
PSEN1 | presenilin 1 | 0.024 | ||
CSF1R | colony stimulating factor 1 receptor | 0.023 | ||
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.023 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.023 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.023 | Human | |
FPR3 | formyl peptide receptor 3 | 0.022 | Human | |
IL1RN | interleukin 1 receptor antagonist | 0.022 | ||
HCK | hemopoietic cell kinase | 0.021 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.021 | ||
IL8 | interleukin 8 | 0.021 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.021 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.021 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.020 | ||
RGS1 | regulator of G-protein signaling 1 | 0.019 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.019 | ||
C3AR1 | complement component 3a receptor 1 | 0.018 | Human | |
CYBB | cytochrome b-245, beta polypeptide | 0.018 | ||
CST7 | cystatin F (leukocystatin) | 0.018 | ||
HMG20A | high mobility group 20A | 0.018 | ||
DARC | Duffy blood group, chemokine receptor | 0.017 | ||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.017 | ||
IL2RG | interleukin 2 receptor, gamma | 0.017 | ||
PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.017 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.017 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.017 | ||
PLEK | pleckstrin | 0.017 | ||
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.017 | Human | |
ADORA3 | adenosine A3 receptor | 0.016 | ||
IFNG | interferon, gamma | 0.016 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.016 | ||
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.016 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.016 | ||
IL21R | interleukin 21 receptor | 0.016 | ||
CDK17 | cyclin-dependent kinase 17 | 0.015 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.015 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.015 | ||
C2 | complement component 2 | 0.015 | ||
TNF | tumor necrosis factor | 0.015 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.015 | ||
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.015 | ||
CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.014 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.014 | ||
NKG7 | natural killer cell group 7 sequence | 0.014 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.014 | ||
IL10RA | interleukin 10 receptor, alpha | 0.014 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
FPR1 | formyl peptide receptor 1 | 0.014 | Human | |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.014 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.014 | ||
SLA | Src-like-adaptor | 0.014 | Human | |
SH2D2A | SH2 domain containing 2A | 0.013 | ||
EGFR | epidermal growth factor receptor | 0.013 | ||
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.013 | ||
PRKCQ | protein kinase C, theta | 0.013 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.013 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.013 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.013 | ||
SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 | 0.013 | ||
ARVCF | armadillo repeat gene deleted in velocardiofacial syndrome | 0.013 | ||
DLG2 | discs, large homolog 2 (Drosophila) | 0.013 | ||
CD80 | CD80 molecule | 0.012 | ||
GZMK | granzyme K (granzyme 3; tryptase II) | 0.012 | ||
GNLY | granulysin | 0.012 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.012 | Human | |
STAT4 | signal transducer and activator of transcription 4 | 0.012 | ||
MARCO | macrophage receptor with collagenous structure | 0.012 | ||
CD52 | CD52 molecule | 0.012 | ||
CTTN | cortactin | 0.012 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.012 | ||
C5AR1 | complement component 5a receptor 1 | 0.012 | Human | |
RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.012 | ||
MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.012 | ||
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.011 | ||
ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.011 | ||
CLEC5A | C-type lectin domain family 5, member A | 0.011 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
CD4 | CD4 molecule | 0.011 | Mouse | |
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
SNX9 | sorting nexin 9 | 0.010 | ||
CD83 | CD83 molecule | 0.010 | ||
SELE | selectin E | 0.010 | ||
ITGB7 | integrin, beta 7 | 0.010 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.010 | ||
WASL | Wiskott-Aldrich syndrome-like | 0.010 | ||
MSR1 | macrophage scavenger receptor 1 | 0.010 | ||
IL1R2 | interleukin 1 receptor, type II | 0.010 |